Camurus: Positive Results in POSITANO - Redeye
Bildkälla: Stockfoto

Camurus: Positive Results in POSITANO - Redeye

Redeye comments on the topline data from the phase II study POSITANO, which investigates the effect of CAM2029 in polycystic liver disease.

Börsvärldens nyhetsbrev